2m 2m 2m 2m 2m 2m 2m
BioAffinity (BIAF)
NASDAQ
$0.85+$0.010 (+1.16%)
Price as of Jun 23, 2026 8:00 PM EDT- $3.8MMarket Cap
- -88.67%1-Year Change
- Diagnostics & ResearchIndustry
BioAffinity (BIAF)
$0.85+$0.010 (+1.16%)
BIAF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.84 | ||
Change | +$0.03 (+4.10%) | ||
Open | $0.80 | ||
High | $0.85 | ||
Low | $0.78 | ||
Previous Close | $0.81 | ||
Volume | 590,498 | ||
30-Day Average Volume | 525,625 | ||
1-Week Change | -10.75% | ||
1-Month Change | -45.95% | ||
1-Year Change | -88.67% | ||
3-Year Change | -98.42% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 4.7M | ||
Total Assets | $7.9M | ||
Market Cap | $3.8M | ||
Enterprise Value | $843,569.00 | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | N/A | ||
Free Cash Flow | -$3.2M | ||
EBIT | $0.00 | ||
EBITDA | $114,518.00 | ||
Net Working Capital | $1.2M | ||
EPS | -$0.81 | ||
Enterprise Value/EBITDA | 7 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | N/A | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 09/19/2025 | ||
Earnings & Revenue